Skip to main navigation Skip to search Skip to main content

C19: An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients with COVID-19

    Project: Research

    Project Details

    StatusActive
    Effective start/end date03/30/20 → …